Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination

PLoS Pathogens
http://journals.plos.org/plospathogens/
[Accessed 4 Dec 2021]

 

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
Chris Davis, Nicola Logan, Grace Tyson, Richard Orton, William T. Harvey, Jonathan S. Perkins, Guy Mollett, Rachel M. Blacow, The COVID-19 Genomics UK (COG-UK) Consortium , Thomas P. Peacock, Wendy S. Barclay, Peter Cherepanov, Massimo Palmarini, Pablo R. Murcia, Arvind H. Patel, David L. Robertson, John Haughney, Emma C. Thomson, Brian J. Willett, on behalf of the COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators
Research Article | published 02 Dec 2021 PLOS Pathogens
https://doi.org/10.1371/journal.ppat.1010022